News Category: Advocacy

CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps. 
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.